Posts tagged: Shire
Shire - there has been some side swapping by rainmakers.. -part 3
Mmmmmm...it sounds like the factoid Betaville spotted in last week's Takeda RNS about the change in advisory line up may be more significant than this website orignally thought.
Digging.....
Shire - there has been some side swapping by rainmakers.. -part 2
Does anybody else think it's curious that Francois Maisonrouge has suddenly vanished from the Takeda RNS statements re Shire?..
RARE ALERT: Shire said to ... - part 3
And now it is on the tape:
Allergan Does Not Intend to Make an Offer for Shire plc; Strategic Review Continues
DUBLIN, April 19, 2018 /PRNewswire/ -- In order to comply with the requirements of the UK Takeover Code, Allergan announced that it does not intend to make an offer for Shire...
RARE ALERT: Shire said to ... - part 2
There was plenty of high drama in the City today around the fate of FTSE 100-listed Shire, some of which wouldn't be too surprising to Betaville Intelligence readers. Below is a link to last Friday's Betaville Intelligence piece on Shire:
https://www.www.betaville.co.uk/betaville-intelligence/rare-alert-shire-said-to/..
RARE ALERT: Shire said to .....
Shire - there has been some side swapping by rainmakers...
Betaville is in a grump. Why? Well, this website prides itself on breaking the top M&A scoops but unfortunately I completely missed the exclusive about Takeda weighing a £35 billion takeover bid for FTSE 100-listed Shire...
Shire said to edge closer to Radius deal - sources - part 2
US-listed Radius Health saw it's shares gain almost 7pc yesterday thanks to a piece on Streetinsider.com about Shire renewing its interest in the business. I have pasted the link to the Streetinsider article below:
http://www.streetinsider.com/dr/news.php?id=12554558&gfv=1..
Shire said to be participating in Merrimack Pharmaceuticals "strategic review" - sources - part 2
There have been a couple of major US biotech deal announcements today, which should cheer a few market watchers up on what on this wet, strike-ridden Monday...
Shire said to be participating in Merrimack Pharmaceuticals "strategic review" - sources
Reuters landed a good story earlier this week about a US biopharmaceutical company called Merrimack Pharmaceuticals carrying out a "strategic review" (banker parlance for a sale or sale of assets). Here is a link to the Reuters piece:
http://www.reuters.com/article/us-merrimack-pharma-m-a-idUSKBN1342QZ..